IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 5422 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4366    
    Printed101    
    Emailed4    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 

 STUDIES
Year : 1995  |  Volume : 61  |  Issue : 5  |  Page : 268--269

Role of colchicine in primary localised cutaneous amyloidosis



Correspondence Address:
K Chakravarty


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20952985

Rights and PermissionsRights and Permissions

Fifteen patients with primary localised cutaneous amyloidosis (PLCA), of which 8 had macular amyloidosis (MA) and 7 lichen amyloidosis (LA), received oral colchicine 1 mg/day in 2 divided doses for a period of 3 months. Pruritus completely disappeared in all MA patients and 30-60% diminution occurred in LA patients within 15 days. Flattening of the papules and diminution in thickness of the skin also started within one month in all LA patients, within 90 days of therapy pigmentation almost disappeared in ail patients of MA and size of papuies decreased by 80-98% in all LA patients. No significant side effect was seen in these patients due to colchicine therapy






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow